BRIM8: a randomized, double-blind, placebo-controlled study of adjuvant vemurafenib in patients (pts) with completely resected, BRAFV600+melanoma at high risk for recurrence
Annals of Oncology(2017)
关键词
adjuvant vemurafenib,melanoma,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要